Literature DB >> 309927

Disease associations of the Ia-like human alloantigens. Contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus.

A Gibofsky, R J Winchester, M Patarroyo, M Fotino, H G Kunkel.   

Abstract

Increasing evidence has been obtained of the special value of Ia-like B-cell alloantisera for demonstrating disease associations with histocompatibility antigens. This was particularly evident for the study of the immunogenetics of rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), two conditions frequently considered related. The profiles of antigens recognized by the alloantisera in patients from each disease group was distinctive. Two types of alloantisera were obtained that illustrated the divergence between the twod iseases. One type showed a higher than normal incidence in RA but lower than normal in SLE; the other showed a higher incidence in SLE. While these sera were not totally defined, evidence was obtained that the SLE-reactive alloantiserum related to two alleles of the major histocompatibility complex DRw2 and DRw3, while the RA-reactive alloantiserum related to a common specificity shared by cells positive for either DRw4, DRw7, or DRw10. The data indicate that immunogenetic factors are relevant to the development of both RA and SLE, but that these are distinct for each disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 309927      PMCID: PMC2185106          DOI: 10.1084/jem.148.6.1728

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  7 in total

1.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

2.  B-lymphocyte alloantigens associated with systemic lupus erythematosus.

Authors:  J L Reinertsen; J H Klippel; A H Johnson; A D Steinberg; J L Decker; D L Mann
Journal:  N Engl J Med       Date:  1978-09-07       Impact factor: 91.245

3.  Serologic recognition of HLA-D-associated determinants.

Authors:  D Albrechtsen; B G Solheim; E Thorsby
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

4.  Studies with B-cell allo- and hetero-antisera: parallel reactivity and special properties.

Authors:  R J Winchester; C Y Wang; J Halper; T Hoffman
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

5.  B-cell alloantigen Ag 7a in multiple sclerosis.

Authors:  R Winchester; G Ebers; S M Fu; L Espinosa; J Zabriskie; H G Kunkel
Journal:  Lancet       Date:  1975-10-25       Impact factor: 79.321

6.  Association of the B-cell alloantigen DRw4 with rheumatoid arthritis.

Authors:  P Stastny
Journal:  N Engl J Med       Date:  1978-04-20       Impact factor: 91.245

7.  Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes.

Authors:  R J Winchester; P Wernet; H G Kunkel; B Dupont; C Jersild; S M Fu
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

  7 in total
  36 in total

Review 1.  Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR.

Authors:  Shu Man Fu; Umesh S Deshmukh; Felicia Gaskin
Journal:  J Autoimmun       Date:  2011-06-01       Impact factor: 7.094

2.  T lymphocyte activation in systemic lupus erythematosus analysed by proliferative response to nucleoplasmic proteins on nitrocellulose immunoblots.

Authors:  B N Pham; L Prin; D Gosset; P Y Hatron; B Devulder; A Capron; J P Dessaint
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

3.  Strong association of rheumatoid arthritis with the presence of a polymorphic Ia epitope defined by a monoclonal antibody: comparison with the allodeterminant DR4.

Authors:  S H Lee; P K Gregersen; H H Shen; A Nunez-Roldan; J Silver; R J Winchester
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

Review 4.  The molecular basis of susceptibility to rheumatoid arthritis: the conformational equivalence hypothesis.

Authors:  R J Winchester; P K Gregersen
Journal:  Springer Semin Immunopathol       Date:  1988

5.  Segregation of lymphocyte low-molecular-weight DNA and antinuclear-antibodies in a family with systemic lupus erythematosus in first cousins.

Authors:  H Levcovitz; M A Fletcher; P Phillips; H A Chertok; R Altman; P J Benke
Journal:  Hum Genet       Date:  1988-11       Impact factor: 4.132

6.  HLA-DR genotype risks in seropositive rheumatoid arthritis.

Authors:  L Legrand; G M Lathrop; A Marcelli-Barge; A Dryll; T Bardin; N Debeyre; J C Poirier; M Schmid; A Ryckewaert; J Dausset
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

7.  Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus.

Authors:  R D Sontheimer; P Stastny; J N Gilliam
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

8.  Implications of the diversity of class I HLA associations in psoriatic arthritis.

Authors:  Robert Winchester; Jon Giles; Deepak Jadon; Muhammed Haroon; Neil McHugh; Oliver FitzGerald
Journal:  Clin Immunol       Date:  2016-07-25       Impact factor: 3.969

9.  Association of HLA-DRw2 with autoimmune thrombocytopenic purpura.

Authors:  S Karpatkin; M Fotino; A Gibofsky; R J Winchester
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

10.  The histocompatibility antigen in asbestos related disease.

Authors:  N Al Jarad; S Uthayakumar; E J Buckland; T S Green; J Ord; A C Newland; R M Rudd
Journal:  Br J Ind Med       Date:  1992-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.